Clinical Trials Directory

Trials / Completed

CompletedNCT04438187

Trial of Antimicrobial Restraint in Presumed Pneumonia

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
186 (actual)
Sponsor
University of Kansas Medical Center · Academic / Other
Sex
All
Age
18 Years – 99 Years
Healthy volunteers
Not accepted

Summary

The objective of this cluster-randomized crossover study is to determine the effect of delaying antimicrobial initiation until objective microbiologic data is obtained in patients with presumed ICU-acquired pneumonia without septic shock.

Detailed description

This study will involve 8 centers is to determine the effect of delaying antimicrobial initiation until objective microbiologic data is obtained in patients with presumed ICU-acquired pneumonia without septic shock. The study team will compare two sequential 4-month periods in each unit, one 'aggressive' antimicrobial initiation period and one 'conservative' antimicrobial initiation period. This study will serve the following specific aims: Specific Aim 1: To determine feasibility of a larger multicenter study of the same design as well as assess protocol adherence across multiple centers. Specific Aim 2: Prospectively determine the all-cause, in-hospital mortality for all patients with suspected pneumonia who were treated under either an aggressive or conservative antimicrobial initiation protocol. Specific Aim 3: Prospectively determine antimicrobial initiation rates, total days of antimicrobial administration, hospital and ICU length of stay, and ventilator-free alive days for patients treated under each protocol. Specific Aim 4: To survey physicians that participated in the study to assess their feelings about the study including level of comfort starting antimicrobials aggressively, level of comfort withholding antimicrobials until definitive evidence of infection, perceived protocol adherence, perceived importance of the study, and willingness to participate in other studies of its kind (to be performed after closure of the clinical portion of the study).

Conditions

Interventions

TypeNameDescription
OTHERantimicrobial initiationantimicrobial initiation based on protocol assignment.

Timeline

Start date
2021-02-01
Primary completion
2022-01-06
Completion
2022-06-30
First posted
2020-06-18
Last updated
2024-08-19

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04438187. Inclusion in this directory is not an endorsement.